Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Miracle cures? UK investigators go after fake coronavirus medicines

Published 04/04/2020, 00:04
Updated 04/04/2020, 04:15

LONDON (Reuters) - British authorities said on Saturday they were clamping down on bogus cures for the coronavirus, which currently has no specific licensed treatment.

The Medicines and Healthcare products Regulatory Agency (MHRA) said it was investigating 14 fake or unlicensed products to treat COVID-19, the respiratory disease caused by the coronavirus.

So far 3,605 Britons have died from the coronavirus, the latest data show, and experts have said deaths will continue to rise until the effect of recent lockdown measures filter through and slow the spread of the disease in the coming weeks.

MHRA said it was investigating fake self-testing kits, miracle cures and so-called "antiviral misting sprays".

"Don't be fooled by online offers for medical products to help prevent or treat COVID-19," Lynda Scammell, MHRA enforcement official said.

"There is no medicine licensed specifically to treat or prevent COVID-19, therefore any claiming to do so are not authorised and have not undergone regulatory approvals required for sale on the UK market."

Scammell added that MHRA was working alongside law enforcement agencies to combat the spread of fake and unlicensed medical products.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.